Proteome analysis of human substantia nigra in Parkinson's disease

被引:209
|
作者
Basso, M
Giraudo, S
Corpillo, D
Bergamasco, B
Lopiano, L
Fasano, M
机构
[1] Univ Insubria, Ctr Neurosci, Arsizio, VA, Italy
[2] Univ Insubria, Dept Struct & Funct Biol, Arsizio, VA, Italy
[3] Univ Turin, Dept Neurosci, Turin, Italy
[4] Bioind Pk Canavese, Colleretto Giacosa, Italy
[5] Salvatore Maugeri Fdn, Pavia, Italy
关键词
excitotoxicity; mitochondrial impairment; oxidative stress; Parkinson's disease; protein expression;
D O I
10.1002/pmic.200400848
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein expression has been compared in human substantia nigra specimens from Parkinson's disease (PD) patients and from controls, and 44 proteins expressed in this midbrain region were identified by peptide mass fingerprinting. Among them, nine showed changes in their abundance. L and M neurofilament chains are less abundant in PD specimens, whereas peroxiredoxin II, mitochondrial complex III, ATP synthase D chain, complexin I, profilin, L-type calcium channel delta-subunit, and fatty-acid binding protein are significantly more present in PD samples than in controls. Besides the consolidated view of oxidative stress involvement in PD pathogenesis, suggested by overexpression of mitochondrial and reactive oxygen species (ROS)-scavenging proteins, these results indicate a possible potentiation mechanism of afferent signals to substantia nigra following degeneration of dopaminergic neurons.
引用
收藏
页码:3943 / 3952
页数:10
相关论文
共 50 条
  • [21] Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no
    Uwe Walter
    Journal of Neural Transmission, 2011, 118 : 607 - 612
  • [22] Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis
    Shafieesabet, Azin
    Fereshtehnejad, Seyed-Mohammad
    Shafieesabet, Azadeh
    Delbari, Ahmad
    Baradaran, Hamid Reza
    Postuma, Ronald B.
    Lokk, Johan
    PARKINSONISM & RELATED DISORDERS, 2017, 42 : 1 - 11
  • [23] Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
    Fabbri, Margherita
    Reimao, Sofia
    Carvalho, Miguel
    Nunes, Rita G.
    Abreu, Daisy
    Guedes, Leonor Correia
    Bouca, Raquel
    Lobo, Patricia P.
    Godinho, Catarina
    Coelho, Miguel
    Goncalves, Nilza C.
    Rosa, Mario Miguel
    Antonini, Angelo
    Ferreira, Joaquim J.
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (03) : 491 - 501
  • [24] Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease
    Menke, Ricarda A.
    Jbabdi, Saad
    Miller, Karla L.
    Matthews, Paul M.
    Zarei, Mojtaba
    NEUROIMAGE, 2010, 52 (04) : 1175 - 1180
  • [25] Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease
    Simon, DK
    Lin, MT
    Zheng, LY
    Liu, GJ
    Ahn, CH
    Kim, LM
    Mauck, WM
    Twu, F
    Beal, MF
    Johns, DR
    NEUROBIOLOGY OF AGING, 2004, 25 (01) : 71 - 81
  • [26] Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease
    Fan, Yongyan
    Ma, Jianjun
    Yang, Dawei
    Li, Xiaohuan
    Liang, Keke
    She, Zonghan
    Qi, Xuelin
    Shi, Xiaoxue
    Gu, Qi
    Zheng, Jinhua
    Li, Dongsheng
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (10) : 2702 - 2714
  • [27] Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease
    Zhou, Hai-Yan
    Huang, Pei
    Sun, Qian
    Du, Juan-Juan
    Cui, Shi-Shuang
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (02) : 333 - 340
  • [28] Substantia nigra echogenicity correlated with clinical features of Parkinson's disease
    Zhou, Hai-Yan
    Sun, Qian
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Li, Dun-Hui
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    PARKINSONISM & RELATED DISORDERS, 2016, 24 : 28 - 33
  • [29] No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease
    Lobsien, Elmar
    Schreiner, Simon
    Plotkin, Michail
    Kupsch, Andreas
    Schreiber, Stephan J.
    Doepp, Florian
    MOVEMENT DISORDERS, 2012, 27 (03) : 450 - 453
  • [30] Neurosteroid Biosynthetic Pathway Changes in Substantia Nigra and Caudate Nucleus in Parkinson's Disease
    Luchetti, Sabina
    Bossers, Koen
    Frajese, Giovanni Vanni
    Swaab, Dick F.
    BRAIN PATHOLOGY, 2010, 20 (05) : 945 - 951